Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On model prespecification in confirmatory randomized studies.

D Edwards1

  • 1Statistics Department, Novo Nordisk A/S, Bagsvaerd, Denmark. DEd@novo.dk

Statistics in Medicine
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tooth wear time-bomb.

British dental journal·2026
Same author

Rapid control of an outbreak of carbapenemase-producing enterobacterales in a recently built, single-bedded, specialist cardiothoracic hospital in England.

The Journal of hospital infection·2026
Same author

Intranetwork variation in neoadjuvant therapy delivery for borderline resectable and locally advanced pancreatic cancer: a UK multicentre cohort study.

Annals of the Royal College of Surgeons of England·2026
Same author

Would endodontic procedures really need antibiotic prophylaxis?

British dental journal·2024
Same author

A Randomised Phase II Trial of Hippocampal Sparing Versus Conventional Whole Brain Radiotherapy After Surgical Resection or Radiosurgery in Favourable Prognosis Patients With 1-10 Brain Metastases.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Systematic review: dorsal bridge plating in distal radius fractures.

Musculoskeletal surgery·2024
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

This study demonstrates that blinded model selection in randomized trials controls the type I error rate, even when the statistical model is data-driven. This ensures reliable treatment effect estimation in pharmaceutical research.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmaceutical Research

Background:

  • Confirmatory randomized trials, particularly in the pharmaceutical industry, aim to detect and quantify treatment effects.
  • Standard practice mandates prespecifying statistical models to prevent data-driven model selection, which can inflate type I error rates.

Purpose of the Study:

  • To demonstrate that concerns about data-driven model selection inflating type I error are unnecessary under specific conditions.
  • To present a method for unbiased estimation of treatment effects when model uncertainty exists.

Main Methods:

  • Utilizing a blinded fashion for statistical model selection.
  • Employing randomization-based tests to assess the null hypothesis of no treatment effect.

Related Experiment Videos

Main Results:

  • Type I error rates are effectively controlled when statistical models are chosen in a blinded manner.
  • A technique for obtaining unbiased treatment effect estimates is described.

Conclusions:

  • Blinded, data-driven model selection combined with randomization-based tests maintains statistical integrity in clinical trials.
  • This approach offers a valuable solution for studies with pre-planned model uncertainty, ensuring reliable results.